Electrochemotherapy: from the drawing board into medical practice
暂无分享,去创建一个
Damijan Miklavčič | Bor Kos | Gregor Serša | Richard Heller | Barbara Mali | D. Miklavčič | G. Serša | R. Heller | B. Mali | B. Kos
[1] L. Mir,et al. Electrochemotherapy: variable anti-tumor effect on different tumor models , 1994 .
[2] Mounir Tarek,et al. Membrane electroporation: a molecular dynamics simulation. , 2005, Biophysical journal.
[3] Julie Gehl,et al. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. , 2012, Cancer research.
[4] Damijan Miklavcic,et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy , 2010, Biomedical engineering online.
[5] Damijan Miklavcic,et al. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases , 2010, Expert review of anticancer therapy.
[6] R. Heller,et al. Delivery of Interleukin-15 to B16 Melanoma by Electroporation Leads to Tumor Regression and Long-term Survival , 2014, Technology in cancer research & treatment.
[7] Richard Heller,et al. In vivo electroporation for gene therapy. , 2006, Human gene therapy.
[8] Martin L. Yarmush,et al. Nonthermal Irreversible Electroporation: Fundamentals, Applications, and Challenges , 2013, IEEE Transactions on Biomedical Engineering.
[9] C. Arena,et al. Advances in Therapeutic Electroporation to Mitigate Muscle Contractions , 2012 .
[10] Aaron S Kesselheim,et al. Regulation of medical devices in the United States and European Union. , 2012, The New England journal of medicine.
[11] D Miklavcic,et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma , 2008, British Journal of Cancer.
[12] J. Malvehy,et al. Desmoplastic melanoma on the nose: electrochemotherapy as an alternative treatment to local advanced disease , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.
[13] L. Löfgren,et al. Electroporation Therapy of Skin Cancer in the Head and Neck Area , 2010, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[14] M. Čemažar,et al. Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy. , 2009, Tumori.
[15] Damijan Miklavcic,et al. Kinetics of transmembrane transport of small molecules into electropermeabilized cells. , 2008, Biophysical journal.
[16] A. Testori,et al. Local and intralesional therapy of in‐transit melanoma metastases , 2011, Journal of surgical oncology.
[17] M. Weichenthal,et al. Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma” , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[18] Ozlem Birgul,et al. In vivo MRI electrical impedance tomography (MREIT) of tumors. , 2006, Technology in cancer research & treatment.
[19] D Miklavcic,et al. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. , 1998, European journal of cancer.
[20] Saptarshi Basu,et al. Patient access to medical devices--a comparison of U.S. and European review processes. , 2012, The New England journal of medicine.
[21] G. Botti,et al. Feasibility of neoadjuvant electrochemotherapy for a large metastatic lesion of the cheek in a patient with melanoma , 2012 .
[22] Damijan Miklavcic,et al. Tumor size and effectiveness of electrochemotherapy , 2013, Radiology and oncology.
[23] D Miklavcic,et al. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] D. Miklavčič,et al. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients , 1995 .
[25] M Cemazar,et al. Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. , 2000, International journal of radiation oncology, biology, physics.
[26] Damijan Miklavčič,et al. Advantages and Disadvantages of Different Concepts of Electroporation Pulse Generation , 2011 .
[27] D. Miklavcic,et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.
[28] M. Jaroszeski,et al. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectrochem , 1995 .
[29] D. Miklavčič,et al. Cell membrane electroporation- Part 1: The phenomenon , 2012, IEEE Electrical Insulation Magazine.
[30] D. Winter,et al. P80. Endoscopically targeted electrochemotherapy for the treatment of colorectal cancer , 2012 .
[31] L. Prosen,et al. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity , 2012, Radiology and oncology.
[32] M. Čemažar,et al. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. , 2005, Anti-cancer drugs.
[33] Gregor Sersa,et al. The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses , 2006 .
[34] E. Neumann,et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.
[35] D Miklavcic,et al. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases , 2000, Melanoma research.
[36] M J Jaroszeski,et al. Toxicity of anticancer agents mediated by electroporation in vitro , 2000, Anti-cancer drugs.
[37] G. Botti,et al. Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma , 2012, Journal of Translational Medicine.
[38] Antonella Vecchiato,et al. Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients , 2008, Annals of Surgical Oncology.
[39] Teissié,et al. Electropermeabilization of cell membranes. , 1999, Advanced drug delivery reviews.
[40] J. Gehl,et al. Electroporation enhances mitomycin C cytotoxicity on T24 bladder cancer cell line: a potential improvement of intravesical chemotherapy in bladder cancer. , 2012, Bioelectrochemistry.
[41] K. Schoenbach,et al. Simulations of transient membrane behavior in cells subjected to a high-intensity ultrashort electric pulse. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.
[42] M. Rols,et al. Electrochemotherapy: progress and prospects. , 2012, Current pharmaceutical design.
[43] Osamu Yamaguchi,et al. Potentiation of effects of anticancer agents by local electric pulses in murine bladder cancer , 2000, Urological Research.
[44] M. Tangney,et al. Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. , 2006, Cancer letters.
[45] C. Cabula. Neoadjuvant electrochemotherapy of breast cancer: our experience on first case treated in Italy , 2013, Updates in Surgery.
[46] D Miklavcic,et al. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[47] P. Capasso,et al. Electrochemotherapy for Non-Melanoma Head and Neck Cancers: Clinical Outcomes in 25 Patients , 2012, Annals of surgery.
[48] M. Jaroszeski,et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.
[49] J. Reizenstein,et al. Electroporation therapy for T1 and T2 oral tongue cancer , 2011, Acta oto-laryngologica.
[50] Jens Ricke,et al. Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study , 2011, CardioVascular and Interventional Radiology.
[51] S. O'sullivan,et al. Electrochemotherapy for the treatment of ocular basal cell carcinoma; a novel adjunct in the disease management. , 2014, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[52] D Miklavcic,et al. Electrochemotherapy in veterinary oncology. , 2008, Journal of Veterinary Internal Medicine.
[53] Boris Rubinsky,et al. Irreversible Electroporation in Medicine , 2007, Technology in cancer research & treatment.
[54] E. Dolgin. Publication checklist proposed to boost rigor of pilot trials , 2013, Nature Medicine.
[55] M Fini,et al. Ablation of bone cells by electroporation. , 2010, The Journal of bone and joint surgery. British volume.
[56] L. Mir,et al. Antitumor electrochemotherapy: New advances in the clinical protocol , 1996, Cancer.
[57] Chad R. Tracy,et al. Irreversible electroporation (IRE): a novel method for renal tissue ablation , 2011, BJU international.
[58] J. Gehl,et al. Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial , 2012, Acta oncologica.
[59] B. Benway. Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study: Pech M, Janitzky A, Wendler JJ, et al (Univ of Magdeburg, Germany) Cardiovasc Intervent Radiol 34:132-138, 2011§ , 2011 .
[60] L. Mir,et al. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.
[61] M. Čemažar,et al. Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice , 2005, BMC Cancer.
[62] D. Peter Tieleman,et al. Electroporating Fields Target Oxidatively Damaged Areas in the Cell Membrane , 2009, PloS one.
[63] Damijan Miklavčič,et al. Planning of Electroporation-Based Treatments Using Web-Based Treatment-Planning Software , 2013, The Journal of Membrane Biology.
[64] Damijan Miklavčič,et al. Patient-specific treatment planning of electrochemotherapy: procedure design and possible pitfalls. , 2012, Bioelectrochemistry.
[65] D Miklavcic,et al. Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. , 2007, Neoplasma.
[66] C. Collins,et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes , 2006 .
[67] D. Miklavčič,et al. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice. , 1997, Cancer letters.
[68] H. Naganuma,et al. Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells , 2000, Brain Research Bulletin.
[69] G. Botti,et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis , 2013, BMC Cancer.
[70] N. Pimpinelli,et al. Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy , 2012, Clinical & Experimental Metastasis.
[71] D Miklavcic,et al. Electrochemotherapy in treatment of tumours. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[72] J. Teissié,et al. Generation of reactive-oxygen species induced by electropermeabilization of Chinese hamster ovary cells and their consequence on cell viability. , 1994, European journal of biochemistry.
[73] B. Rubinsky,et al. Tissue Ablation with Irreversible Electroporation , 2005, Annals of Biomedical Engineering.
[74] R. Heller. Treatment of cutaneous nodules using electrochemotherapy. , 1995, The Journal of the Florida Medical Association.
[75] S. Mocellin,et al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma , 2012, The British journal of surgery.
[76] Damijan Miklavčič,et al. Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study , 2006 .
[77] P. Rutkowski,et al. Effective treatment of recurrent, advanced dermatofibrosarcoma protuberans by electrochemotherapy. , 2013, European journal of dermatology : EJD.
[78] T. Jarm,et al. Electrochemotherapy , 2011, Technology in cancer research & treatment.
[79] H. Schwan. Electrical properties of tissue and cell suspensions. , 1957, Advances in biological and medical physics.
[80] A. Finazzi Agro',et al. Role of lipid peroxidation in electroporation-induced cell permeability. , 1995, Biochemical and biophysical research communications.
[81] Helen Kavnoudias,et al. Irreversible Electroporation: A New Challenge in “Out of Operating Theater” Anesthesia , 2010, Anesthesia and analgesia.
[82] D Miklavcic,et al. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. , 1995, Cancer research.
[83] Damijan Miklavcic,et al. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors , 2012, Medical and Biological Engineering and Computing.
[84] Luigi Corti,et al. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study , 2012, Breast Cancer Research and Treatment.
[85] Damijan Miklavcic,et al. Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation , 2012, Physics in medicine and biology.
[86] M. Okino,et al. Optimal Electric Conditions in Electrical Impulse Chemotherapy , 1992, Japanese journal of cancer research : Gann.
[87] M. Gargiulo,et al. Electrochemotherapy: actual considerations and clinical experience in head and neck cancers. , 2010, Annals of surgery.
[88] L. Borgognoni,et al. Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation , 2012, Oncoimmunology.
[89] Damijan Miklavčič,et al. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy , 2006 .
[90] Elisabetta Sieni,et al. Electrochemotherapy Treatment of Locally Advanced and Metastatic Soft Tissue Sarcomas: Results of a Non-Comparative Phase II Study , 2014, World Journal of Surgery.
[91] Boris Rubinsky,et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. , 2011, AJR. American journal of roentgenology.
[92] Julie Gehl,et al. Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions. , 2014, Biochimica et biophysica acta.
[93] L. Mir,et al. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice , 1997 .
[94] J Teissié,et al. Control by ATP and ADP of voltage-induced mammalian-cell-membrane permeabilization, gene transfer and resulting expression. , 1998, European journal of biochemistry.
[95] Richard Heller,et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] Boris Rubinsky,et al. Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation , 2009, PloS one.
[97] Carlo Bartolozzi,et al. Targeting Liver Lesions for Radiofrequency Ablation: An Experimental Feasibility Study Using a CT–US Fusion Imaging System , 2008, Investigative radiology.
[98] T. Jarm,et al. An algorithm for synchronization of in vivo electroporation with ECG , 2005, Journal of medical engineering & technology.
[99] A. Testori,et al. Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach , 2010, Dermatologic therapy.
[100] S. Bagla,et al. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. , 2012, Journal of vascular and interventional radiology : JVIR.
[101] M. Tangney,et al. Electrochemotherapy: Aspects of Preclinical Development and Early Clinical Experience , 2007, Annals of surgery.
[102] A. Eggermont,et al. Surgical management of melanoma: an EORTC Melanoma Group survey , 2013, Ecancermedicalscience.
[103] Lucie Delemotte,et al. Molecular Dynamics Simulations of Lipid Membrane Electroporation , 2012, The Journal of Membrane Biology.
[104] M J Jaroszeski,et al. In vivo antitumor effects of electrochemotherapy in a hepatoma model. , 1997, Biochimica et biophysica acta.
[105] Stuart K. Roberts,et al. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience and Review of Safety and Outcomes , 2013, Technology in Cancer Research and Treatment.
[106] D Miklavcic,et al. The importance of electric field distribution for effective in vivo electroporation of tissues. , 1998, Biophysical journal.
[107] Faisal Mahmood,et al. Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. , 2011, Bioelectrochemistry.
[108] L. Mir,et al. Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors , 2008, Therapeutics and clinical risk management.
[109] J. Gehl,et al. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy , 2000, Melanoma research.
[110] M. Okino,et al. Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. , 1987, Japanese journal of cancer research : Gann.
[111] M. Čemažar,et al. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation. , 2006, Anticancer research.
[112] M. Čemažar,et al. Differential Mechanisms Associated with Vascular Disrupting Action of Electrochemotherapy: Intravital Microscopy on the Level of Single Normal and Tumor Blood Vessels , 2013, PloS one.
[113] M. Jaroszeski,et al. Electrically enhanced drug delivery for the treatment of soft tissue sarcoma , 1999, Cancer.
[114] S. Calvieri,et al. Electrochemotherapy in the Treatment of Kaposi Sarcoma Cutaneous Lesions: A Two-Center Prospective Phase II Trial , 2011, Annals of Surgical Oncology.
[115] D. Miklavčič,et al. Intrinsic Sensitivity of Tumor Cells to Bleomycin as an Indicator of Tumor Response to Electrochemotherapy , 1998, Japanese journal of cancer research : Gann.
[116] Damijan Miklavcic,et al. Robustness of Treatment Planning for Electrochemotherapy of Deep-Seated Tumors , 2010, The Journal of Membrane Biology.
[117] Helle K. Iversen,et al. Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy , 2012, Radiology and oncology.
[118] L. Mir,et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.
[119] V. Sondak,et al. Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[120] J. Gehl,et al. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs , 1998, Anti-cancer drugs.
[121] Damijan Miklavcic,et al. The effect of electroporation pulses on functioning of the heart , 2008, Medical & Biological Engineering & Computing.
[122] Juergen F Kolb,et al. Membrane permeabilization and cell damage by ultrashort electric field shocks. , 2007, Archives of biochemistry and biophysics.
[123] J. Gehl,et al. Management of cutaneous metastases using electrochemotherapy , 2011, Acta oncologica.
[124] L. Mir,et al. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. , 2001, European journal of cancer.
[125] M. Jaroszeski,et al. In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity , 2000, Melanoma research.